维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="van TASSELL BW"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice 显示文摘	Van Tassell BW Varma A Salloum FN	2010	J Cardiovasc Pharmaeol2010，55，2：	1
2	Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?显示文摘	Abbate A Canada JM van Tassell BW et ed	2014	Int J Cardiol2014，171，：	1
3	Interleukin - 18 as a therapeutic target in acute myocardial infarction and heart fail- ure显示文摘	OBrien LC Mezzaroma E Van Tassel] BW	2014	Mo] Med2014，20，：	1
4	Medication nonadherence: an unr cardiovascular risk factor显示文摘	Munger MA Van Tassell BW LaFleur J	2007	Med Gen Med2007，9，3：	1
5	Targeting interleukin-1 in heart disease显示文摘	van Tassell BW Toldo S Mezzaroma E	2013	Circulation2013，128，17：	1
6	Targeting interleukin-1 in heart failure and inflammatory heart disease显示文摘	van Tassell BW Raleigh JM Abbate A	2015	Curt Heart Fail Rep2015，12，1：	1
7	Blocking inter- leukin-1 as a novel therapeutic strategy for secondary preven- tion of cardiovascular events 显示文摘	Abbate A Van Tassell BW Biondi-Zoceai GG	2012	Bio Drugs2012，26，4：	1
8	Enhanced interleu- kin- 1 activity contributes to exercise intolerance in patients with systolic heart failure显示文摘	Van Tassell BW Arena RA Stefano T	2012	PLoS One2012，7，33：	1
9	Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure 显示文摘	van Tassell BW Radwanski P Movsesian M	2008	Pharmacotherapy2008，28，12：	1
10	Medication nonadherence:an unrecognized cardiovascular risk factor显示文摘	Munger MA Van Tassell BW LaFleur J		0，，：	1
11	Interleukin 18 as a therapeutic target in acute myocardial infarction and heart failure 显示文摘	Obrien LC Mezzaroma E van Tassell BW	2014	Mol Med2014，20，1：	1
12	Interleu- kin-18 as a therapeutic target in acute myocardial infarc- tion and heart failure 显示文摘	OBrien LC Mezzaroma E Van Tassell BW	2014	Mol Med2014，20，1：	1
13	Controversy and conflict in the treatment of acute decompensated heart failure:nesiritide as evidence-based treatment显示文摘	Munger MA Ng TM van Tassell BW	2007	Pharmaeotherapy2007，27，5：	1
14	Interleukin-18 as a therapeutic target in acute myocardial infarction and heart fail- ure显示文摘	O'Brien LC Mezzaroma E Van Tassell BW	2014	Mol Med2014，20，1：	1
15	lntefleukin-1 beta mod- ulation using a genetically engineered antibody prevents adverse cardi- ac remodelling following acute myocardial infarction in the mouse 显示文摘	Abbate A Van Tassell BW Seropian lM	2010	European journal of heart failure2010，12，4：	1
16	Interleukin-1 trap attenuates cardiac remodeling after experimental acutemyocardial infarction in mice显示文摘	Van Tassell BW Varma A Salloum FN	2010	J Cardiovasc Pharmacol2010，55，2：	1
17	Interleukinlbeta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse显示文摘	Abbate A Van Tassell BW Seropian IM	2010	Eur J Heart Fail2010，12，4：	1
18	Aliskiren for renin inhibition: a new class of antihypertensives显示文摘	Van Tassell BW Munger MA	2007	Ann Pharmacother2007，41，3：	1
19	Medication nonadherence : an unrecognized cardiovascular risk factor显示文摘	Munger MA Van Tassell BW LaFleur J	2007	MedGenMed2007，9，3：	1
20	Pharmacologic inhibition of myeloid differentiation factor 88(My D88)prevents left ventricular dilation and hypertrophy after experimental acute myocardial infarction in the mouse显示文摘	Van Tassell BW Seropian IM Toldo S	2010	J Cardiovasc Pharmacol2010，55，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示